<DOC>
	<DOCNO>NCT00448383</DOCNO>
	<brief_summary>This open-label , multi-center study adalimumab ( D2E7 ) administer subcutaneously 40 mg every week addition current anti-rheumatic therapy . Patients must active disease despite standard anti-rheumatic therapy .</brief_summary>
	<brief_title>A Study Assess Safety Efficacy Adalimumab When Added Inadequate Standard Anti-Rheumatic Therapy Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subjects must 18 year old ACR criterion diagnosis RA least 3 month . Active RA define DAS28 &gt; = 3.2 study entry . Unsatisfactory response intolerance prior DMARDs . A negative pregnancy test ( serum HCG ) woman childbearing potential prior start study treatment . Use reliable method contraception e.g . IUDs , condom , hormone ( oral , implantable , injectable ) contraceptive female patient childbearing potential . Male patient procreative capacity also ensure effective contraception use study 70 day study completion Prior treatment alkylating agent cyclophosphamide chlorambucil . Prior treatment intravenous immunoglobulin investigational agent within 30 day , 5 half life product , whichever longer . Prior treatment investigational biologic therapy ( e.g . anti CD4 ) Treatment within last 2 month approve biologic therapy ( eg etanercept , infliximab , anakinra ) Prior treatment total lymphoid irradiation History cancer lymphoproliferative disease successfully completely treat squamous cell basal cell carcinoma . History current acute inflammatory joint disease origin RA , e.g . mixed connective tissue disease , systemic lupus erythematosus etc . History uncontrolled diabetes , unstable ischemic heart disease , active inflammatory bowel disease , active peptic ulcer disease , recent stroke ( within 3 month ) condition , opinion investigator , would put subject risk participation protocol . Positive serology hepatitis B C indicate active infection History positive HIV status . Persistent infection , severe infection require hospitalization treatment iv antibiotic within 30 day , oral antibiotic within 14 day prior enrollment . Female subject pregnant breastfeeding . History clinically significant drug alcohol abuse last year . Previous diagnosis sign demyelinate disease History active tuberculosis ( TB ) , histoplasmosis listeriosis . Signs previous TB infection ( chest Xray sign positive PPD skin test ) . The diagnosis previous TB infection base chest Xray sign PPD skin test .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>